Guselkumab does not appear to influence the IgG antibody response to SARS-CoV-2

Dermatol Ther. 2022 Feb;35(2):e15246. doi: 10.1111/dth.15246. Epub 2021 Dec 10.

Authors

Dillon Mintoff¹, Farida Benhadou²

Affiliations

¹ Department of Dermatology, Mater Dei Hospital, Msida, Malta.
² Dermatology Department, Erasme Hospital, Université Libre de Bruxelles, Bruxelles, Belgium.

PMID: 34865295
DOI: 10.1111/dth.15246

No abstract available

Publication types

Letter

MeSH terms

Antibodies, Monoclonal, Humanized
Antibody Formation
COVID-19*
Humans
Immunoglobulin G
SARS-CoV-2*

Substances

Antibodies, Monoclonal, Humanized
Immunoglobulin G
guselkumab